Literature DB >> 12746247

Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Louise-Anne McNutt1, Chuntao Wu, Xiaonan Xue, Jean Paul Hafner.   

Abstract

Logistic regression yields an adjusted odds ratio that approximates the adjusted relative risk when disease incidence is rare (<10%), while adjusting for potential confounders. For more common outcomes, the odds ratio always overstates the relative risk, sometimes dramatically. The purpose of this paper is to discuss the incorrect application of a proposed method to estimate an adjusted relative risk from an adjusted odds ratio, which has quickly gained popularity in medical and public health research, and to describe alternative statistical methods for estimating an adjusted relative risk when the outcome is common. Hypothetical data are used to illustrate statistical methods with readily accessible computer software.

Mesh:

Year:  2003        PMID: 12746247     DOI: 10.1093/aje/kwg074

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  760 in total

1.  Trends in Breastfeeding Disparities in US Infants by WIC Eligibility and Participation.

Authors:  Qi Zhang; Rajan Lamichhane; Mia Wright; Patrick W McLaughlin; Brian Stacy
Journal:  J Nutr Educ Behav       Date:  2018-12-01       Impact factor: 3.045

2.  Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.

Authors:  David I Buckley; James F Calvert; Jodi A Lapidus; Cynthia D Morris
Journal:  Ann Fam Med       Date:  2010 May-Jun       Impact factor: 5.166

3.  Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Paul Craig Nathan; Kirsten Kimberlie Ness; Martin Christopher Mahoney; Zhenghong Li; Melissa Maria Hudson; Jennifer Sylene Ford; Wendy Landier; Marilyn Stovall; Gregory Thomas Armstrong; Tara Olive Henderson; Leslie L Robison; Kevin Charles Oeffinger
Journal:  Ann Intern Med       Date:  2010-10-05       Impact factor: 25.391

4.  Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease.

Authors:  Barry Kurt Moser; Susan Halabi
Journal:  Stat Med       Date:  2011-12-09       Impact factor: 2.373

5.  Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression.

Authors:  Mirjam J Knol; Saskia Le Cessie; Ale Algra; Jan P Vandenbroucke; Rolf H H Groenwold
Journal:  CMAJ       Date:  2011-12-12       Impact factor: 8.262

6.  Vertebroplasty and balloon kyphoplasty in osteoporosis: friends or foes?

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

7.  Association of Patient Age With Progression of Low-risk Papillary Thyroid Carcinoma Under Active Surveillance: A Systematic Review and Meta-analysis.

Authors:  Alexandra Koshkina; Rouhi Fazelzad; Iwao Sugitani; Akira Miyauchi; Lehana Thabane; David P Goldstein; Sangeet Ghai; Anna M Sawka
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-06-01       Impact factor: 6.223

8.  Comparing unmet needs between community-based palliative care patients with heart failure and patients with cancer.

Authors:  Dio Kavalieratos; Arif H Kamal; Amy P Abernethy; Andrea K Biddle; Timothy S Carey; Sandesh Dev; Bryce B Reeve; Morris Weinberger
Journal:  J Palliat Med       Date:  2014-03-03       Impact factor: 2.947

9.  Religiosity and Excess Weight Among African-American Adolescents: The Jackson Heart KIDS Study.

Authors:  Marino A Bruce; Bettina M Beech; Tanganyika Wilder; E Thomaseo Burton; Jylana L Sheats; Keith C Norris; Roland J Thorpe
Journal:  J Relig Health       Date:  2020-02

10.  Familial risk of urinary incontinence in women: population based cross sectional study.

Authors:  Yngvild S Hannestad; Rolv Terje Lie; Guri Rortveit; Steinar Hunskaar
Journal:  BMJ       Date:  2004-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.